
Clinical Resources
Find the most up-to-date clinical guidelines, tools, courses, and more.
Resources
By Disease
Find clinical resources and information for common movement disorders:
Clinical Tools
Evidence-Based Medicine Reviews
Review the latest recommendations from MDS's Evidence-Based Medicine Reviews, which use a rigorous methodological approach to outline treatment options.
For Underserved Areas & Populations
Resources to help you better understand and address the needs of a variety of underserved patients.
Education
Courses for Clinicians
Browse live, in-person and on-demand courses tailored to clinicial care.
Approach and Management of Restless Legs Syndrome
On Demand
60 Minutes
Foundational / Beginner
1133 <p>This course offers an in-depth exploration of Restless Legs Syndrome (RLS), covering the pathophysiology of RLS, latest diagnostic criteria, key differential diagnoses, and evidence-based treatment approaches, including pharmacological and non-pharmacological options.<br /></p> Other Movement Disorders, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD) Luigi Ferini-Strambi, MD, Maria Paola Mogavero, MD, PhD 60 1.00 https://education.movementdisorders.org/Detail/1133/Approach-and-Management-of-Restless-Legs-Syndrome https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-51-001-rls-202x1087655.jpg 2026-09-18T00:00:00 2029-09-18T00:00:00 <p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final Disclosure Block_Approach and Management of Restless Legs Syndrome_16092026115929.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p><span style="background-color: null;">Luigi Ferini-Strambi, MD - Vita Salute Raffaele Turro - Milan, Italy</span></p><p>Maria Paola Mogavero, MD, PhD - Oasi Research Institute IRCCS, Troina, Italy, Adjunct Professor of Neurology, University of Milan, Italy</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon the completion of this activity, learners will be able to:</p><p>1. Explain the epidemiology, causes, and pathophysiology of RLS.</p><p>2. Apply disgnostic criteria to accurately identify RLS and distinguish it from similar conditions.</p><p>3. Analyze the pharmacologic and non-pharmacologic treatment options to develop individualized RLS management plans.</p><p>4. Evaluate treatment responses and complications, including augmentation and adverse effects, to optimize ongoing care.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Approach-and-Management-of-Restless-Legs-Syndrome.htm Approach and Management of Restless Legs Syndrome 2026-09-18T12:00:53.307 0 0 Foundational / Beginner On-Demand Other Movement Disorders
Affiliate Society Video Case Series
Live Online
Oct 31, 2026 - Feb 27, 2027
Foundational / Beginner
1151 <p>The MDS-AOS Affiliate Society Video Case Series is a live, interactive educational program designed to enhance diagnostic reasoning in movement disorders through expert-guided discussion of authentic clinical video cases. Each session features case presentations from two MDS-AOS affiliate societies followed by panel discussions led by international experts. The three-session series will focus on contemporary themes in movement disorders, including genetic disorders, movement disorders beyond the basal ganglia, and movement disorders that require prompt recognition because of their therapeutic or prognostic implications.</p><p> </p><p><strong>SESSION 1 REGISTRATION DEADLINE:</strong> October 29, 2026<strong><span style="background-color:#ffffff;color:#000000;"></span></strong><span style="background-color:#ffffff;color:#000000;"></span></p> Ataxias, Biomarkers, Biomarkers & Diagnostic Tools, Drug-induced Movement Disorders/Tardive dyskinesia, Functional Movement Disorders, Gait & Balance Disorders, Genetic & Hereditary Disorders, Genetics, Movement Disorders Emergencies, Neuroimaging, Neuropathology, Other Movement Disorders, Rare/Uncommon Movement Disorders, Rating Scales, Restless Legs Syndrome (RLS)/Periodic Limb Movement Disorder (PLMD), Stiff Person syndrome (SPS) 360 0.00 https://education.movementdisorders.org/Detail/1151/MDS-AOS-Affiliate-Society-Video-Case-Series https://education.movementdisorders.org/Upload/ActivityImages/25AOSSERIE-VideoCases_202x108721193.jpg https://education.movementdisorders.org/Upload/BannerImages/26AOSSERIE_783x40470253.jpg 2026-10-31T00:00:00 2027-02-27T00:00:00 <p><br></p><p><br></p> MDS Education <p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSSERIE%20Course%20Schedule_30092026014416.pdf"><img width="87" height="87" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1756240577504_26082025033615.png" class="fr-fic fr-dii"></a><!--[endif]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSSERIE%20Course%20Schedule_30092026014416.pdf"><strong>Course Schedule</strong></a><strong> </strong><strong> </strong><!--[if !vml]--><!--[if !vml]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSSERIE%20Faculty%20Listing_30092026013325.pdf"><img width="98" height="98" src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/1756240577600_26082025033616.png" class="fr-fic fr-dii"></a><!--[endif]--><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/26AOSSERIE%20Faculty%20Listing_30092026013325.pdf"><strong>Course Faculty</strong></a><strong> </strong></p><p><br></p><p><em>Schedule as of September 30, 2026 </em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong> $0 USD<br><strong>Non-Members:</strong> $0 USD</p><p><br></p><p><strong>COURSE DETAILS</strong><em><br></em><strong>Session 1: Genetics in Movement Disorders </strong></p><p><em>Saturday, October 31, 2026: 04:00 - 06:00 UTC</em></p><p>Cases Presented By: </p><ol><li>Saudi Neurology Society - Movement Disorders Chapter</li><li>Neurological Association of Uzbekistan</li></ol><p><strong>Session 2: Beyond the Basal Ganglia </strong></p><p><em>Saturday, December 5, 2026: 04:00 - 06:00 UTC</em></p><p><br></p><p><strong>Session 3: Movement Disorders You Can’t Afford to Miss </strong></p><p><em>Saturday, February 27, 2027: 04:00 - 06:00 UTC</em></p><p><br></p><p><br></p><p><em>To convert to your local time, please click here: </em><span style="color: rgb(44, 130, 201);"><a href="https://www.timeanddate.com/worldclock/converter.html"><em>https://www.timeanddate.com/worldclock/converter.html</em></a></span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p><span style="color: rgb(0, 0, 0);">Upon completion of this activity, learners will be able to:</span></p><ol><li><span style="color: rgb(0, 0, 0);">Recognize characteristic phenomenological features of selected movement disorders using clinical video cases</span></li><li><span style="color: rgb(0, 0, 0);">Compare disorders with similar clinical presentations and formulate appropriate differential diagnoses</span></li><li><span style="color: rgb(0, 0, 0);">Identify clinical features suggestive of genetic disorders and movement disorders arising outside the basal ganglia</span></li><li><span style="color: rgb(0, 0, 0);">Recognize movement disorders requiring urgent evaluation or disease-specific treatment</span></li><li><span style="color: rgb(0, 0, 0);">Apply expert diagnostic reasoning to challenging movement disorder cases in clinical practice</span></li></ol><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for movement disorder specialists, general neurologists, primary care clinicians, clinical fellows, movement disorder fellows, neurology residents, and medical students with an interest in current clinical trends and approaches for diagnosis and treatment of movement disorders.</p> 0 /Courses/Affiliate-Society-Video-Case-Series.htm Affiliate Society Video Case Series 2026-09-01T12:00:55.500 0 0 Foundational / Beginner Live Online Biomarkers & Diagnostic Tools Other Movement Disorders
Neurodegeneration with Brain Iron Accumulation
On Demand
60 Minutes
Foundational / Beginner
1121 <span style="line-height:115%;">This course aims to provide you with a structured understanding of the approach and management of neurodegeneration with brain iron accumulation. Upon completion of this course, you will be able to discuss different types of neurodegeneration with brain iron accumulations, including age of onset, clinical manifestations, and genetics; differential diagnosis of neurodegeneration with brain iron accumulations and approach to diagnosis including imaging; as well as review treatment approaches in neurodegeneration with brain iron accumulations.</span> Biomarkers, Biomarkers & Diagnostic Tools, Cognitive impairment/Dementia, Genetic & Hereditary Disorders, Genetics, Medications for motor symptoms, Neuroimaging, Neuropathology, Non-motor Symptoms/Disorders, Other Movement Disorders, Physical Therapy/Physiotherapy, Rating Scales, Sensory disorders, Speech Disorders, Therapies-Other, Therapies-Pharmacological Susanne Schneider, MD, Soaham Desai, MD, DM 60 1.00 https://education.movementdisorders.org/Detail/1121/Neurodegeneration-with-Brain-Iron-Accumulation https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-47-001-Neurodegeneration-with-Brain-Iron-Accumulation--202x108626849.jpg https://education.movementdisorders.org/Upload/BannerImages/05INTERACT-47-001-Neurodegeneration-with-Brain-Iron-Accumulation-734x404812281.jpg 2026-08-21T00:00:00 2029-08-21T00:00:00 <p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available<a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Final%20Disclosure%20Block_Neurodegeneration%20with%20Brain%20Iron%20Accumulation_14072026110011.pdf" rel="noopener noreferrer" target="_blank"> HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p><span style="background-color: null;">Susanne A. Schneider, MD - University Medical Center of the Johannes, Gutenberg University - Mainz, Germany</span></p><p><span style="background-color: null;">Soaham Desai, MD, DM - Shree Krishna Hospital, Pramukhswami Medical College, Bhaikaka University, Karamsad - Anand, Gujarat, India</span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Discuss different types of NBIA, including age of onset. clinical manifestations, and genetics</p><p>2. Discuss the differential diagnosis of NBIAs and approach to diagnosis, including imaging.</p><p>3. Review treatment approaches in NBIAs.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Neurodegeneration-with-Brain-Iron-Accumulation.htm Neurodegeneration with Brain Iron Accumulation 2026-08-21T00:01:01.720 0 0 Foundational / Beginner On-Demand Biomarkers & Diagnostic Tools Non-motor Symptoms/Disorders Other Movement Disorders Therapies-Other Therapies-Pharmacological
Journal CME 41.08: Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers
On Demand
60 Minutes
Experienced / Intermediate
1147 <p>The Journal CME 41.08 article aims to characterize the volumetric and neurometabolic brain changes in GCH1 mutation carriers (MC) and explore their relationship with clinical severity.</p> Basal Ganglia, Biomarkers, Biomarkers & Diagnostic Tools, Dystonia, Etiology & Pathophysiology, Genetics, Hyperkinetic Movement Disorders, Neuroimaging, Neuropathology, Rating Scales Jannik Prasuhn, MD 60 1.00 https://education.movementdisorders.org/Detail/1147/Journal-CME-41-08:-Metabolic-and-Volumetric-Alterations-in-the-Basal-Ganglia-and-the-Cerebellum-in-Dopa-Responsive-Dystonia-in-Symptomatic-and-Asymptomatic-GCH1-Mutation-Carriers https://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg 2026-08-14T00:00:00 2027-08-14T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2041.08%20-%20Disclosures_12082026085638.pdf" rel="noopener noreferrer" target="_blank"><u>HERE</u></a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Understand the role of GCH1 and tetrahydrobiopterin in dopamine synthesis</p><p>2. Assess the clinical and imaging methods used to characterize GCH1-related DRD</p><p>3. Evaluate structural and metabolic changes in the basal ganglia and cerebellum associated with GCH1-related DRD</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Journal-CME-41.08-Metabolic-and-Volumetric-Alterations-in-the-Basal-Ganglia-and-the-Cerebellum-in-Dopa-Responsive-Dystonia-in-Symptomatic-and-Asymptomatic-GCH1-Mutation-Carriers.htm Journal CME 41.08: Metabolic and Volumetric Alterations in the Basal Ganglia and the Cerebellum in Dopa-Responsive Dystonia in Symptomatic and Asymptomatic GCH1 Mutation Carriers Journal CME 41.08 2026-08-14T18:00:53.077 0 0 Experienced / Intermediate On-Demand Biomarkers & Diagnostic Tools Etiology & Pathophysiology Hyperkinetic Movement Disorders
Other Educational Resources
Get More Clinical Support

Join MDS
Members gain access to case videos, peer-to-peer collaboration opportunities, discounted education, and a variety of specialized programs.

Attend the International Congress
Discover the latest in the field, and connect with leaders from around the globe.
















